In the original published version of this article, the term “FoxiangSan” is misspelled as “FuxiangSan” in Fig. 8.
Fig. 8.
The diagram depicting the mechanism illustrates how FoxiangSan alleviates gastroparesis symptoms related to Type 2 Diabetes Mellitus (T2DM), by modulating both the cAMP/PKA signaling pathway and the gut microbiome.
Please refer to the screenshot from the original published online article below for clarity:
The corrected Fig. 8 is as shown below:
The authors apologise for the error. Both the HTML and PDF versions of the article have been updated to correct the errors.
Declaration of competing interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.